Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.

Giovanni Franchin, M.D, Ph.D · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
covidpneumonia
covid-19 pneumonia, viral pneumonia, pneumonia, covid-19, covid, protein kinase inhibitors, enzyme inhibitors, molecular mechanisms of pharmacological action, irak 4 inhibitor, sars-cov-2 pneumonia, irak-4 inhibitor in sars-cov-2 pneumonia, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 876052
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.